Search filters

List of works by Peter Ferenci

Age and Sex but Not ATP7B Genotype Effectively Influence the Clinical Phenotype of Wilson Disease

scientific article published on 01 March 2019

Are all cirrhotic patients equal?

scientific article published on 06 November 2019

Are the new genetic tools for diagnosis of Wilson disease helpful in clinical practice?

scientific article published on 18 April 2020

Bis-choline tetrathiomolybdate in patients with Wilson's disease: an open-label, multicentre, phase 2 study

scientific article published on 5 October 2017

Changes in Hepatic Venous Pressure Gradient Predict Hepatic Decompensation in Patients Who Achieved Sustained Virologic Response to Interferon-Free Therapy

scientific article published on 14 October 2019

Dynamics of platelet count after sustained virologic response do not mirror those of hepatic venous pressure gradient

scientific article published on 28 October 2019

Editorial: are additional tests needed to predict sustained virologic response in hepatitis C treated with interferon-free direct-acting antiviral combinations?

scientific article published in March 2018

Encephalopathy in Wilson disease: copper toxicity or liver failure?

scientific article

Ethyl glucuronide in hair detects a high rate of harmful alcohol consumption in presumed non-alcoholic fatty liver disease

scientific article published on 20 May 2022

Impact of HSD17B13 rs72613567 genotype on hepatic decompensation and mortality in patients with portal hypertension

scientific article published on 03 December 2019

Impact of farnesoid X receptor single nucleotide polymorphisms on hepatic decompensation and mortality in cirrhotic patients with portal hypertension

scientific article published on 14 June 2019

Impact of patatin-like phospholipase domain containing 3 rs738409 G/G genotype on hepatic decompensation and mortality in patients with portal hypertension.

scientific article published on 29 June 2018

Late-onset Wilson's disease

scientific article

Non-invasive diagnosis of cirrhosis and long-term disease monitoring by transient elastography in patients with Wilson disease

scientific article published on 22 January 2020

Non-invasive risk stratification after HCV-eradication in patients with advanced chronic liver disease

scientific article published on 13 July 2020

Real-world safety and effectiveness of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin in hepatitis C virus genotype 1- and 4-infected patients with diverse comorbidities and comedications: A pooled analysis of post-marketing observational

scientific article published on 05 March 2019

Retreatment with telaprevir combination therapy in hepatitis C patients with well-characterized prior treatment response

scientific article published in November 2011

Revisiting liver disease progression in HIV/HCV-coinfected patients: the influence of vitamin D, insulin resistance, immune status, IL28B and PNPLA3.

scientific article published on 26 June 2014

Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension

scientific article

Telaprevir and peginterferon with or without ribavirin for chronic HCV infection

scientific article published on April 2009

The Impact of PNPLA3 rs738409 SNP on Liver Fibrosis Progression, Portal Hypertension and Hepatic Steatosis in HIV/HCV Coinfection

scientific article published on 23 November 2015

Transplantation of hepatitis D virus patients: Lifelong hepatitis B immunoglobulins?

scientific article published on 29 June 2022

WTX101 - an investigational drug for the treatment of Wilson disease

scientific article published on 08 June 2018

Wilson disease

article published in 2018